Statin reduces the incidence of diabetic retinopathy and its need for intervention: A systematic review and meta-analysis
- 1 May 2021
- journal article
- review article
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 31 (3), 1216-1224
- https://doi.org/10.1177/1120672120922444
Abstract
Purpose: We aimed to perform a systematic literature search on the latest evidence of the role of statin in reducing diabetic retinopathy and its need for intervention. Methods: A comprehensive search on cohort studies/clinical trials that assess statins and diabetic retinopathy up until August 2019 was performed. The outcome measured was the incidence of diabetic retinopathy and its need for intervention. Results: There were 558.177 patients from six studies. Statin was associated with a lower incidence of diabetic retinopathy (hazard ratio: 0.68 (0.55, 0.84), p < 0.001; I-2: 95%). For the subtypes of diabetic retinopathy, statin lowers the incidence of proliferative diabetic retinopathy (hazard ratio: 0.69 (0.51, 0.93), p = 0.01; I-2: 90%), non-proliferative diabetic retinopathy (hazard ratio: 0.80 (0.66, 0.96), p = 0.02; I-2: 93%), and diabetic macular edema (hazard ratio: 0.56 (0.39, 0.80), p = 0.002; I-2: 82%). Statin was associated with a reduced need for retinal laser treatment with a hazard ratio of 0.70 (0.64, 0.76) (p < 0.001; I-2: 0%), intravitreal injection with a hazard ratio of 0.82 (0.79, 0.85) (p < 0.001; I-2: 0%), and vitrectomy with a hazard ratio of 0.64 (0.48, 0.85) (p < 0.001; I-2: 75%). Overall, statin was associated with a reduced need for intervention for diabetic retinopathy with a hazard ratio of 0.72 (0.64, 0.80) (p < 0.001; I-2: 73%). The regression-based Egger's test showed statistically significant small-study effects for non-proliferative diabetic retinopathy (p = 0.011) outcomes. Conclusion: Statin was associated with a decreased risk of diabetic retinopathy and its subtypes. Statin also reduced the need for intervention with retinal laser treatment, intravitreal injection, and vitrectomy.Keywords
This publication has 34 references indexed in Scilit:
- Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemiaCanadian Journal of Physiology and Pharmacology, 2014
- Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched studyThe Lancet Diabetes & Endocrinology, 2014
- Low intravitreal angiopoietin‐2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatmentActa Ophthalmologica, 2014
- Statins for the primary prevention of cardiovascular diseaseCochrane Database of Systematic Reviews, 2013
- Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008Jama-Journal Of The American Medical Association, 2012
- The worldwide epidemic of diabetic retinopathyIndian Journal Of Ophthalmology, 2012
- Update of the ACCORD Eye StudyNew England Journal of Medicine, 2011
- Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesNew England Journal of Medicine, 2010
- Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialThe Lancet, 2007
- Association of Statin Use With the Risk of Developing Diabetic RetinopathyAmerican Journal of Ophthalmology, 2007